Follow
Fedor N Novikov
Fedor N Novikov
Pharmenterprises LLC
Verified email at pharmenterprises.ru - Homepage
Title
Cited by
Cited by
Year
Lead finder: An approach to improve accuracy of protein− ligand docking, binding energy estimation, and virtual screening
OV Stroganov, FN Novikov, VS Stroylov, V Kulkov, GG Chilov
Journal of Chemical Information and Modeling 48 (12), 2371-2385, 2008
2222008
Lung fibrosis after COVID-19: treatment prospects
E Bazdyrev, P Rusina, M Panova, F Novikov, I Grishagin, V Nebolsin
Pharmaceuticals 14 (8), 807, 2021
1512021
PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation
AA Mian, A Rafiei, I Haberbosch, A Zeifman, I Titov, V Stroylov, ...
Leukemia 29 (5), 1104-1114, 2015
642015
Quantifying possible routes for SpnF-catalyzed formal Diels–Alder cycloaddition
MG Medvedev, AA Zeifman, FN Novikov, IS Bushmarinov, OV Stroganov, ...
Journal of the American Chemical Society 139 (11), 3942-3945, 2017
442017
Lead Finder docking and virtual screening evaluation with Astex and DUD test sets
FN Novikov, VS Stroylov, AA Zeifman, OV Stroganov, V Kulkov, GG Chilov
Journal of computer-aided molecular design 26, 725-735, 2012
412012
Molecular docking: theoretical background, practical applications and perspectives
FN Novikov, GG Chilov
Mendeleev Communications 5 (19), 237-242, 2009
412009
Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin
M Sagnou, FN Novikov, ES Ivanova, P Alexiou, VS Stroylov, IY Titov, ...
European Journal of Medicinal Chemistry 198, 112331, 2020
352020
TSAR, a new graph–theoretical approach to computational modeling of protein side‐chain flexibility: Modeling of ionization properties of proteins
OV Stroganov, FN Novikov, AA Zeifman, VS Stroylov, GG Chilov
Proteins: Structure, Function, and Bioinformatics 79 (9), 2693-2710, 2011
352011
CSAR scoring challenge reveals the need for new concepts in estimating protein–ligand binding affinity
FN Novikov, AA Zeifman, OV Stroganov, VS Stroylov, V Kulkov, GG Chilov
Journal of chemical information and modeling 51 (9), 2090-2096, 2011
322011
Exhaustive conformational search for transition states: the case of catechol O-methyltransferase active site
MG Medvedev, MV Panova, GG Chilov, IS Bushmarinov, FN Novikov, ...
Mendeleev Communications 27 (3), 224-227, 2017
242017
Molecular basis of COVID-19 pathogenesis
FN Novikov, VS Stroylov, IV Svitanko, VE Nebolsin
Russian Chemical Reviews 89 (8), 858, 2020
232020
PF‑114, a novel selective inhibitor of BCR‑ABL tyrosine kinase, is a potent inducer of apoptosis in chronic myelogenous leukemia cells
ES Ivanova, VV Tatarskiy, MA Yastrebova, AI Khamidullina, AV Shunaev, ...
International Journal of Oncology 55 (1), 289-297, 2019
232019
Improving performance of docking-based virtual screening by structural filtration
FN Novikov, VS Stroylov, OV Stroganov, GG Chilov
Journal of molecular modeling 16, 1223-1230, 2010
232010
Developing novel approaches to improve binding energy estimation and virtual screening: a PARP case study
FN Novikov, VS Stroylov, OV Stroganov, V Kulkov, GG Chilov
Journal of molecular modeling 15, 1337-1347, 2009
232009
PF-114: a 4th generation tyrosine kinase-inhibitor for chronic phase chronic myeloid leukaemia including BCRABL1T315I
AG Turkina, O Vinogradova, E Lomaia, E Shatokhina, OA Shukhov, ...
Blood 134, 1638, 2019
192019
Novel Antitumor L‐Arabinose Derivative of Indolocarbazole with High Affinity to DNA
DN Kaluzhny, VV Tatarskiy Jr, LG Dezhenkova, IL Plikhtyak, TD Miniker, ...
ChemMedChem: Chemistry Enabling Drug Discovery 4 (10), 1641-1648, 2009
192009
Rational design and synthesis of new PARP1 inhibitors
LV Romashov, AA Zeifman, AL Zakharenko, FN Novikov, VS Stroilov, ...
Mendeleev Communications 22 (1), 15-17, 2012
182012
Phase-1 study of PF-114 mesylate in CML failing prior tyrosine kinase-inhibitor therapy
AG Turkina, O Vinogradova, E Lomaia, E Shatokhina, O Shukhov, ...
Blood 132, 790, 2018
172018
Molecular modeling of different substrate‐binding modes and their role in penicillin acylase catalysis
FN Novikov, OV Stroganov, IG Khaliullin, NV Panin, IV Shapovalova, ...
The FEBS Journal 280 (1), 115-126, 2013
172013
Alchemical FEP calculations of ligand conformer focusing in explicit solvent
AA Zeifman, VV Stroylov, FN Novikov, OV Stroganov, V Kulkov, GG Chilov
Journal of Chemical Theory and Computation 9 (2), 1093-1102, 2013
152013
The system can't perform the operation now. Try again later.
Articles 1–20